Please enable Javascript to use all features and improve your user experience.
DGM 2023
Programme
People
Search
DE
All people
Dr. med. Christopher Nelke
Düsseldorf / DE
Universitätsklinikum Düsseldorf
Sort by Type
Date
Speaker
22/03/2023
Poster
P 53
Cellular senescence is a prominent feature of inclusion body myositis
Biomarker - molekular, klinisch, digital, Pathophysiologie und molekulare Mechanismen
Further involvements
22/03/2023
Poster
P 86
Beyond complement - proteometabolomics identify the versatile consequences of eculizumab treatment in myasthenia gravis
Pathophysiologie und molekulare Mechanismen, Therapie
22/03/2023
Poster
P 53
Cellular senescence is a prominent feature of inclusion body myositis
Biomarker - molekular, klinisch, digital, Pathophysiologie und molekulare Mechanismen
22/03/2023
Poster
P 56
A simplified murine model of experimental autoimmune myasthenia gravis (EAMG)
Biomarker - molekular, klinisch, digital, Pathophysiologie und molekulare Mechanismen
22/03/2023
Poster
P 4
Periostin level in sporadic inclusion body myositis: a study of blood and muscle
Biomarker - molekular, klinisch, digital, Pathophysiologie und molekulare Mechanismen
22/03/2023
Poster
P 22
A case of triple-A syndrome associated with a novel pathogenic AAAS variant
Case reports
23/03/2023
15:25
–
15:30
4 Min.
1 Min.
Orales Poster
P 4
Periostin level in sporadic inclusion body myositis: a study of blood and muscle
Biomarker - molekular, klinisch, digital, Pathophysiologie und molekulare Mechanismen
24/03/2023
15:35
–
15:40
4 Min.
1 Min.
Orales Poster
P 56
A simplified murine model of experimental autoimmune myasthenia gravis (EAMG)
Biomarker - molekular, klinisch, digital, Pathophysiologie und molekulare Mechanismen
24/03/2023
16:10
–
16:15
4 Min.
1 Min.
Orales Poster
P 86
Beyond complement - proteometabolomics identify the versatile consequences of eculizumab treatment in myasthenia gravis
Pathophysiologie und molekulare Mechanismen, Therapie
24/03/2023
16:10
–
16:20
10 Min.
0 Min.
Freier Vortrag
FV 24
Molecular deciphering of disease processes in SLC12A6-associated sensorimotor neuropathy
Biomarker - molekular, klinisch, digital, Pathophysiologie und molekulare Mechanismen
24/03/2023
17:30
–
17:40
10 Min.
0 Min.
Freier Vortrag
FV 28
Proteomic profiling identifies ITIH3 as biomarker for disease activity in myasthenia gravis
Biomarker - molekular, klinisch, digital, Pathophysiologie und molekulare Mechanismen
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy